Bio-Techne (TECH) Assets Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.12% |
| Dec 31, 2025 | 4.06% |
| Sep 30, 2025 | 4.23% |
| Jun 30, 2025 | 4.76% |
| Mar 31, 2025 | 5.75% |
| Dec 31, 2024 | 5.97% |
| Sep 30, 2024 | 7.28% |
| Jun 30, 2024 | 7.49% |
| Mar 31, 2024 | 7.76% |
| Dec 31, 2023 | 8.16% |
| Sep 30, 2023 | 8.04% |
| Jun 30, 2023 | 10.62% |
| Mar 31, 2023 | 9.95% |
| Dec 31, 2022 | 8.73% |
| Sep 30, 2022 | 9.01% |
| Jun 30, 2022 | 8.05% |
| Mar 31, 2022 | 8.44% |
| Dec 31, 2021 | 8.68% |
| Sep 30, 2021 | 8.39% |
| Jun 30, 2021 | 14.91% |
| Mar 31, 2021 | 13.19% |
| Dec 31, 2020 | 12.78% |
| Sep 30, 2020 | 12.72% |
| Jun 30, 2020 | 13.78% |
| Mar 31, 2020 | 12.60% |
| Dec 31, 2019 | 12.30% |
| Sep 30, 2019 | 13.58% |
| Jun 30, 2019 | 16.92% |
| Mar 31, 2019 | 17.66% |
| Dec 31, 2018 | 18.12% |
| Sep 30, 2018 | 19.16% |
| Jun 30, 2018 | 15.41% |
| Mar 31, 2018 | 16.30% |
| Dec 31, 2017 | 16.51% |
| Sep 30, 2017 | 16.47% |
| Jun 30, 2017 | 16.72% |
| Mar 31, 2017 | 17.52% |
| Dec 31, 2016 | 19.48% |
| Sep 30, 2016 | 19.28% |
| Jun 30, 2016 | 12.83% |
| Mar 31, 2016 | 14.00% |
| Dec 31, 2015 | 15.33% |
| Sep 30, 2015 | 15.90% |
| Jun 30, 2015 | 15.43% |
| Jun 30, 2014 | 12.81% |